Monday, September 14, 2026

UEFA’s Shift: Why the European Football Association is Ending FIFA Boycott Plans

UEFA plans to withdraw its boycott of FIFA events, but demands for FIFA President Gianni Infantino's resignation will continue.

Lee Jung-hoo’s Struggles: Can He Bounce Back After Tough Game Against Pirates?

Lee Jung-hoo of the San Francisco Giants only managed one walk in six plate appearances.

Top 5 Promising Lung Cancer Treatments Revealed at WCLC 2026: What You Need to Know

The world's largest conference on lung cancer will be held in Seoul after 19 years, showcasing clinical results from local pharmaceutical firms.

Tag: biopharmaceuticals

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

“Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target

Celltrion is expected to outperform its first-half results in the second half, driven by new-product growth, European tender wins and stronger demand for high-margin products, potentially allowing it to exceed its full-year targets.

Alteogen Signs $365 Million License Deal With Global Pharma Company for SC Platform Technology

Alteogen has signed an exclusive licensing agreement with a global pharmaceutical company for the development of subcutaneous biopharmaceuticals.

HyDIFFUZE™: The Game-Changer in Subcutaneous ADC Delivery for Cancer Treatment

Huons Lab patents a platform technology for ADC subcutaneous injections, enhancing stability and drug delivery efficiency in biopharmaceuticals.

SK Telecom, SK Biopharmaceuticals Use AI to Identify Drug Candidates for Hard-to-Treat Cancer Targeted Therapies

SK Telecom and SK Biopharmaceuticals use AI to identify early-stage cancer therapy candidates, reducing drug discovery time by over 60%.

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

Lotte Biologics’ ‘Three Production Batches, 14% Utilization’ Underscores Need for New Orders Over New Plants

Lotte Biologics aims to enter the global CDMO market by expanding production, but faces challenges in securing contracts and profitability.

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Alteogen CEO Says Additional Licensing Deals Near Completion, Highlights Patent Strength [BIO USA]

Alteogen is nearing global licensing deals, focusing on maximizing value and expanding its platform technology in biopharma.

SK Biopharm CEO Lee Dong-hoon: “AI and open innovation are key to drug development” [BIO USA]

SK Biopharmaceuticals focuses on open innovation and AI for drug development, aiming to enhance CNS therapies and expand into new modalities.

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Samsung Epis Holdings Earns MSCI AA Rating in First Global ESG Assessment

Samsung Epis Holdings earns an AA ESG rating from MSCI, highlighting its commitment to sustainable management and biopharmaceutical growth.

Samsung Biologics Highlights CRDO and Organoid Platforms at PEGS Boston

Samsung Biologics showcased its CRDO capabilities at PEGS Boston, enhancing cancer drug development with innovative organoid technology.

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.